Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

Presentation TCT 2024

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Presenter: Ulf Teichgräber

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

Presentation TCT 2023

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

Presenter: Kazuki Tobita

October 25, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

Shelley Wood

January 31, 2020

Presentation TCT 2019

LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Presenter: Kenneth Ouriel

September 28, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

Presentation

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

February 11, 2019

Podcast TCTMD Talking Points

DES for Femoropopliteal Disease: IMPERIAL

January 09, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

Presentation TCT 2018

IN.PACT DCB: Pooled Multistudy Assessment of Drug-Coated Balloon Treatment for Femoropopliteal Peripheral Artery Disease

Presenter: Lindsay S. Machan, Craig M. Walker, Mehdi H. Shishehbor

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

Presentation

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

May 08, 2018

Presentation TCT 2017

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Presenter: David P. Faxon, Joseph A. Hill, Yusuke Miyashita

October 31, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

Presentation TCT 2016

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

Presenter: Thomas F. Luscher, Patrick W. Serruys, D. Christopher Metzger

October 31, 2016

News Daily News

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

Caitlin E. Cox

November 15, 2015

Advertisement

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

What’s Going to Be Big at TCT 2024?

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

What’s Going to Be Hot at ACC 2024

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

TCTMD’s Top 10 Most Popular Stories for January 2020

LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease

DES for Femoropopliteal Disease: IMPERIAL

TCTMD’s Top 10 Most Popular Stories for September 2018

IN.PACT DCB: Pooled Multistudy Assessment of Drug-Coated Balloon Treatment for Femoropopliteal Peripheral Artery Disease

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with Complex Femoropopliteal Lesions

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content